id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1998-N-1169-0002,FDA,FDA-1998-N-1169,"Reference 4 re Cost-effectiveness of expanded human immunodeficiency
virus-testing protocols for donated blood",Supporting & Related Material,Background Material,2015-11-18T05:00:00Z,2015,11,,,2015-11-20T15:10:13Z,,0,0,0900006481d50fa9
FDA-1998-N-1169-0001,FDA,FDA-1998-N-1169,Notice of Proposed Rulemaking re Requirements for Testing Human Blood Donors for Evidence of Infection Due to Communicable Disease Agens,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2015-11-18T05:00:00Z,2015,11,1999-08-19T04:00:00Z,1999-11-18T04:59:59Z,2015-11-20T15:09:08Z,,0,0,09000064805a3304